Yinghong Li, Yuanhui Zhang, Tianyu Niu, Yudong Pang, Yulong Shi, Qingxuan Zeng, Jingpu Zhang, Jingyang Zhu, Xiuli Zhong, Yanxiang Wang, Yan Wang, Sheng Tang, Weijia Kong, Danqing Song, Jiandong Jiang
摘要 (
)
PDF全文 (
)
HTML
可视化
收藏
We found compound 12N-p-trifluoromethylbenzenesulfonyl matrinane (1) was a potent anti-diabetic agent. Thirty-five tricyclic matrinic derivatives were synthesized and determined for their stimulatory effects on glucose consumption in L6 myotubes, taking1 as the lead. In high-fat diet (HFD) and STZ induced diabetic mice,9a significantly lowers blood glucose, improves glucose tolerance, and especially alleviates diabetic nephropathy and islet damage. Mechanism study indicates that9a simultaneously targets mitochondrial complex I to increase AMP/ATP ratio, as well as liver kinase B1 (LKB1) and calcium/calmodulin-dependent protein kinase (CaMKK), which synergistically activates AMPKα and then stimulates glucose transporter 4 (GLUT4) membrane translocation and 2-deoxyglucose (2-DG) uptake to exert anti-diabetic efficacy. Therefore, compound9a with a novel structure is a promising anti-diabetic candidate with the advantage of multiple-target mechanism, worthy of further investigation.